August 2022 "Psychedelic research across different disciplines and biological levels is growing at a remarkably fast pace. In the prospect of a psychedelic drug becoming again an approved treatment, much of these efforts have been oriented toward exploring the relationship between the actual psychedelic effects and those manifestations of therapeutic interest. Considering the central role of the serotonin 5-HT2A receptor in the distinct effects of psychedelics in human psyche, neuropharmacology sits at the center of this debate and exploratory continuum. Here we discuss some of the most recent findings in human studies and contextualize them considering previous preclinical models studying phenomena related to synaptic plasticity. A special emphasis is placed on knowledge gaps, challenges, and limitations to evaluate the underpinnings of psychedelics' potential antidepressant action." Read more at the source #DrGPCR #GPCR #IndustryNews

Axelrod Symposium: Plant-derived molecules acting on GPCRs Molecular characterization of recombinant LSDV

Perspective on Class C GPCR Based Genetically Encoded Biosensors Emergence of lumpy skin disease virus (LSDV

Authors and Affiliations Gross JD -1 (lead author, presenter) Kohlenbach LM -2 Zhou Y -1 Marugan JJ -3 Barak LS -1 (senior author) 1-Department of Cell Biology, Duke University Medical Center, Durham, NC 27710

Larry Barak (1994) Dr. Kathleen Caron - Co-host- (1970) Dr. Steve Ferguson (1995) Dr.

melanocortin 4 receptor signaling Photo-induced receptor confinement drives ligand-independent GPCR signaling LSD